content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <headerData>
  <submissionType>144</submissionType>
  <filerInfo>
  <filer>
  <filerCredentials>
  <cik>0001529196</cik>
  <ccc>XXXXXXXX</ccc>
  </filerCredentials>
  </filer>
  <liveTestFlag>LIVE</liveTestFlag>
  </filerInfo>
  </headerData>
  <formData>
  <issuerInfo>
  <issuerCik>0001479290</issuerCik>
  <issuerName>Revance Therapeutics, Inc.</issuerName>
  <secFileNumber>001-36297</secFileNumber>
  <issuerAddress>
  <street1 xmlns="http://www.sec.gov/edgar/common">1222 Demonbreun St</street1>
  <street2 xmlns="http://www.sec.gov/edgar/common">Suite 2000</street2>
  <city xmlns="http://www.sec.gov/edgar/common">Nashville</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">TN</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">37203</zipCode>
  </issuerAddress>
  <issuerContactPhone>615-724-7755</issuerContactPhone>
  <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Mark Foley</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
  <relationshipsToIssuer>
  <relationshipToIssuer>Officer</relationshipToIssuer>
  </relationshipsToIssuer>
  </issuerInfo>
  <securitiesInformation>
  <securitiesClassTitle>COMMON </securitiesClassTitle>
  <brokerOrMarketmakerDetails>
  <name>E*TRADE FINANCIAL CORPORATION</name>
  <address>
  <street1 xmlns="http://www.sec.gov/edgar/common">3 EDISON DRIVE</street1>
  <city xmlns="http://www.sec.gov/edgar/common">ALPHARETTA</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">GA</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">30005</zipCode>
  </address>
  </brokerOrMarketmakerDetails>
  <noOfUnitsSold>70000</noOfUnitsSold>
  <aggregateMarketValue>2338000</aggregateMarketValue>
  <noOfUnitsOutstanding>84000000</noOfUnitsOutstanding>
  <approxSaleDate>05/12/2023</approxSaleDate>
  <securitiesExchangeName>NASD</securitiesExchangeName>
  </securitiesInformation>
  <securitiesToBeSold>
  <securitiesClassTitle>Revance Common</securitiesClassTitle>
  <acquiredDate>05/11/2023</acquiredDate>
  <natureOfAcquisitionTransaction>RSU Vesting</natureOfAcquisitionTransaction>
  <nameOfPersonfromWhomAcquired>Revance Therapeutics</nameOfPersonfromWhomAcquired>
  <isGiftTransaction>N</isGiftTransaction>
  <amountOfSecuritiesAcquired>70000</amountOfSecuritiesAcquired>
  <paymentDate>05/11/2023</paymentDate>
  <natureOfPayment>cash</natureOfPayment>
  </securitiesToBeSold>
  <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
  <securitiesSoldInPast3Months>
  <sellerDetails>
  <name>Mark Foley</name>
  <address>
  <street1 xmlns="http://www.sec.gov/edgar/common">1222 Demonbreun St</street1>
  <street2 xmlns="http://www.sec.gov/edgar/common">Suite 2000</street2>
  <city xmlns="http://www.sec.gov/edgar/common">Nashville</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">TN</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">37203</zipCode>
  </address>
  </sellerDetails>
  <securitiesClassTitle>Revance Common</securitiesClassTitle>
  <saleDate>03/09/2023</saleDate>
  <amountOfSecuritiesSold>70390</amountOfSecuritiesSold>
  <grossProceeds>2223360</grossProceeds>
  </securitiesSoldInPast3Months>
  <remarks>Shares sold to cover taxes from a RSU vest</remarks>
  <noticeSignature>
  <noticeDate>05/12/2023</noticeDate>
  <signature>Mark Foley</signature>
  </noticeSignature>
  </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 3452}]
text: 144
  0001529196
  XXXXXXXX
  LIVE
  0001479290
  Revance Therapeutics, Inc.
  001-36297
  1222 Demonbreun St
  Suite 2000
  Nashville
  TN
  37203
  615-724-7755
  Mark Foley
  Officer
  COMMON
  E*TRADE FINANCIAL CORPORATION
  3 EDISON DRIVE
  ALPHARETTA
  GA
  30005
  70000
  2338000
  84000000
  05/12/2023
  NASD
  Revance Common
  05/11/2023
  RSU Vesting
  Revance Therapeutics
  N
  70000
  05/11/2023
  cash
  N
  Mark Foley
  1222 Demonbreun St
  Suite 2000
  Nashville
  TN
  37203
  Revance Common
  03/09/2023
  70390
  2223360
  Shares sold to cover taxes from a RSU vest
  05/12/2023
  Mark Foley